BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2135694)

  • 1. Use of a specific monoclonal antibody to detect Mallory bodies in liver disease.
    Leevy CB; Sameshima Y; Yoshioka K; Leevy CM; Kanagasundaram N; Unoura M
    J Assoc Acad Minor Phys; 1990; 1(2):24-5, 28-30. PubMed ID: 2135694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High molecular weight component of Mallory bodies detected by a monoclonal antibody.
    Zatloukal K; Denk H; Spurej G; Lackinger E; Preisegger KH; Franke WW
    Lab Invest; 1990 Apr; 62(4):427-34. PubMed ID: 1692099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural, biochemical, and immunologic characterization of Mallory bodies in livers of griseofulvin-treated mice. Fimbriated rods of filaments containing prekeratin-like polypeptides.
    Franke WW; Denk H; Schmid E; Osborn M; Weber K
    Lab Invest; 1979 Feb; 40(2):207-20. PubMed ID: 219290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of immunohistochemically detected small Mallory bodies in liver disease.
    Yoshioka K; Kakumu S; Tahara H; Arao M; Fuji A; Hirofuji H; Hayashi T; Kano H
    Am J Gastroenterol; 1989 May; 84(5):535-9. PubMed ID: 2719010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of Mallory bodies to the cytoskeleton of hepatocytes in griseofulvin-treated mice.
    Irie T; Benson NC; French SW
    Lab Invest; 1982 Oct; 47(4):336-45. PubMed ID: 6889660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin is present on the cytokeratin intermediate filaments and Mallory bodies of hepatocytes.
    Ohta M; Marceau N; Perry G; Manetto V; Gambetti P; Autilio-Gambetti L; Metuzals J; Kawahara H; Cadrin M; French SW
    Lab Invest; 1988 Dec; 59(6):848-56. PubMed ID: 2462130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High molecular weight components are main constituents of Mallory bodies isolated with a fluorescence activated cell sorter.
    Zatloukal K; Böck G; Rainer I; Denk H; Weber K
    Lab Invest; 1991 Feb; 64(2):200-6. PubMed ID: 1705301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change of cytokeratin organization during development of Mallory bodies as revealed by a monoclonal antibody.
    Hazan R; Denk H; Franke WW; Lackinger E; Schiller DL
    Lab Invest; 1986 May; 54(5):543-53. PubMed ID: 2422438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mallory bodies compared with microfilament hyperplasia.
    Sim JS; Franks KE; French SW; Caldwell MG
    Arch Pathol Lab Med; 1977 Aug; 101(8):401-4. PubMed ID: 195552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of mallory body formation induced by okadaic acid in drug-primed mice.
    Yuan QX; Nagao Y; Gaal K; Hu B; French SW
    Exp Mol Pathol; 1998 Oct; 65(2):87-103. PubMed ID: 9828150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental Mallory body formation is accompanied by modulation of the expression of multidrug-resistance genes and their products.
    Preisegger KH; Stumptner C; Riegelnegg D; Brown PC; Silverman JA; Thorgeirsson SS; Denk H
    Hepatology; 1996 Jul; 24(1):248-52. PubMed ID: 8707270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electron microscopic study of the in vitro calcium-dependent degradation of Mallory bodies and intermediate filaments in hepatocytes.
    Irie T; Benson NC; French SW
    Lab Invest; 1984 Mar; 50(3):303-12. PubMed ID: 6199585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rearrangement of the hepatocyte cytoskeleton after toxic damage: involution, dispersal and peripheral accumulation of Mallory body material after drug withdrawal.
    Denk H; Franke WW
    Eur J Cell Biol; 1981 Feb; 23(2):241-9. PubMed ID: 7193580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone enhances mallory body formation in drug-primed mouse liver.
    Yuan QX; Nagao Y; French BA; Wan YJ; French SW
    Exp Mol Pathol; 2000 Dec; 69(3):202-10. PubMed ID: 11115361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is apoptosis involved in alcoholic hepatitis?
    Kawahara H; Matsuda Y; Takase S
    Alcohol Alcohol Suppl; 1994; 29(1):113-8. PubMed ID: 9063809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a mutant ER-retained polytope membrane protein in cultured rat hepatocytes results in Mallory body formation.
    Hirano K; Roth J; Zuber C; Ziak M
    Histochem Cell Biol; 2002 Jan; 117(1):41-53. PubMed ID: 11819096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the cytokeratin intermediate filament cytoskeleton associated with Mallory body formation in mouse and human liver.
    Katsuma Y; Swierenga SH; Khettry U; Marceau N; French SW
    Hepatology; 1987; 7(6):1215-23. PubMed ID: 2445643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infiltrating polymorphonuclear leukocytes and apoptotic bodies derived from hepatocytes but not from ballooning hepatocytes containing Mallory bodies show nuclear DNA fragmentation in alcoholic hepatitis.
    Takahashi T; So-Wan T; Kamimura T; Asakura H
    Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):68S-73S. PubMed ID: 10803784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin: an immunohistochemical marker of Mallory bodies and alcoholic liver disease.
    Vyberg M; Leth P
    APMIS Suppl; 1991; 23():46-52. PubMed ID: 1652996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modifications in cytokeratin and actin in cultured liver cells derived from griseofulvin-fed mice.
    Cadrin M; Anderson NM; Aasheim LH; Kawahara H; Franks DJ; French SW
    Lab Invest; 1995 Apr; 72(4):453-60. PubMed ID: 7536860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.